2012•Zhongguo redai yixueRequires access

Effect of alprostadil combined with mosapride on diabetic gastroparesis patients

Hailong Zheng, Haifeng Wang, Wang Zhuan-suo

Abstract

Objective To observe the therapeutic outcome of alprostadil combined with mosapride on diabetic gastroparesis patients.Methods A total of 60 patients with diabetic gastroparesis were randomly divided into treatment group(n=30)treated with mosapride in combination with alprostadil and control group(n=30)only treated with mosapride for a course of 4 weeks.clinical symptoms and gastroscopy were observed before treatment and 4 weeks after treatment.Results The total effective rate was 93.3%(28/30)higher significantly in the treatment group Compared with the control group(73.3%)(P0.05).No obvious side effects were observed.Conclusion The clinical efficacy of alprostadil combined with mosapride is effective and safe for treatment of diabetic gastroparesis patients.

About this research paper

What this paper is about

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Mosapride, Gastroparesis, Medicine, Gastroenterology, Internal medicine, Clinical efficacy, Diabetes mellitus, Anesthesia